Patent Assignment
Reel/Frame 025416/0381
Security Agreement
Recorded: 2010-12-01
Received: 2010-12-01
Pages: 11
Assignor
ENDO PHARMACEUTICALS INC.
Executed: 2010-11-30
Assignee
JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
10 SOUTH DEARBORN, CHICAGO, IL, 60603, UNITED STATES
Covered Properties
(36)
Abuse-Resistant Opioid Dosage Form
Application:
12/894,614 →
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Application:
12/716,973 →
Oxymorphone Controlled Release Formulations
Application:
12/426,112 →
Oxymorphone Controlled Release Formulations
Application:
12/167,859 →
Opioid and Methods of Making and Using the Same
Application:
12/119,841 →
Transdermal Delivery Form Disposal Systems and Methods
Application:
12/048,771 →
Abuse-resistant controlled-release opioid dosage form
Application:
11/901,232 →
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
Application:
11/766,748 →
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment
Application:
11/766,727 →
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Application:
11/766,740 →
Immediate Release Oxymorphone Compositions and Methods of Using Same
Application:
11/742,206 →
Oxymorphone Controlled Release Formulations
Application:
11/680,432 →
Treatment of Xerostomia
Application:
11/605,983 →
Dosage limiting medication dispensing method and apparatus
Application:
11/497,510 →
Oxymorphone Controlled Release Formulations
Application:
11/427,438 →
Oxymorphone Controlled Release Formulations
Application:
11/426,170 →
Oxymorphone Controlled Release Formulations
Application:
11/425,966 →
Sustained release oxycodone composition with acrylic polymer and metal hydroxide
Application:
11/447,714 →
Sustained release oxycodone composition with acrylic polymer and surfactant
Application:
11/447,560 →
Method for deterring abuse of opioids by combination with non-release formulation of emetic
Application:
11/361,929 →
Method for treating non-neuropathic pain
Application:
11/336,001 →
Abuse-resistant opioid solid dosage form
Application:
10/514,387 →
Pharmaceutical composition and method for treating disorders of the central nervous system
Application:
10/501,678 →
Abuse resistant opioid dosage form
Application:
10/514,390 →
Controlled release dosage forms using acrylic polymer, and process for making
Application:
10/501,798 →
Analgesics and methods of use
Application:
10/501,692 →
Compositions and methods for treating neuropathic sensory loss
Application:
10/722,737 →
Method for the Treatment of Urinary Incontinence
Application:
10/394,038 →
Method of Treating Mucositis
Application:
10/317,633 →
Carbinols for the Treatment of Neuropathic Dysfunction
Application:
10/272,375 →
Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
Application:
10/245,139 →
Oxymorphone controlled release formulations
Application:
10/190,192 →
Abuse-resistant opioid dosage form
Application:
10/143,140 →
Abuse resistant pharmaceutical composition containing capsaicin
Application:
10/118,110 →
Antimicrobial Solutions
Application:
09/851,365 →
Anticonvulsant Containing Composition for Treating Neuropathic Pain
Application:
09/780,858 →